Clinical trial
A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the…
NCT00215436 · Dey, Industry · Completed
Key facts
| NCT number | NCT00215436 |
|---|---|
| Title | A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD |
| Official title | A 12-week Double-Blind, Parallel-Group, Placebo- and Active- Controlled Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate Inhalation Solution 20 Mcg in the Treatment of Patients With Chronic Obstructive Pulmonary Disease |
| Lead sponsor | Dey, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | COPD |
| Intervention type | Drug |
| Interventions | Formoterol Fumarate |
| Enrollment | 345 |
| Start date | Mar 1, 2005 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Nov 10, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: